Daigle D M, McKay G A, Wright G D
Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada L8N 3Z5.
J Biol Chem. 1997 Oct 3;272(40):24755-8. doi: 10.1074/jbc.272.40.24755.
Bacterial resistance to the aminoglycoside antibiotics is manifested primarily through the expression of enzymes which covalently modify these drugs. One important mechanism of aminoglycoside modification is through ATP-dependent O-phosphorylation, catalyzed by a family of aminoglycoside kinases. The structure of one of these kinases, APH(3')-IIIa has recently been determined by x-ray crystallography, and the general fold is strikingly similar to eukaryotic protein kinases (Hon, W. C., McKay, G. A., Thompson, P. R., Sweet, R. M., Yang, D. S. C., Wright, G. D., and Berghuis, A. M. (1997) Cell 89, 887-895). Based on this similarity, we have examined the effect of known inhibitors of eukaryotic protein kinases on two aminoglycoside kinases, APH(3')-IIIa and the enzyme AAC(6')-APH(2") which also exhibits acetyl-CoA-dependent aminoglycoside modification activity. We report that several known protein kinase inhibitors are also good inhibitors of aminoglycoside kinases. Compounds belonging to the isoquinolinesulfonamide group are especially effective in this regard, giving competitive inhibition in the micromolar range with respect to ATP and noncompetitive inhibition versus the aminoglycoside substrate. This study provides the basis for future aminoglycoside kinase inhibitor design and for the development of compounds which could reverse antibiotic resistance in the clinic.
细菌对氨基糖苷类抗生素的耐药性主要通过共价修饰这些药物的酶的表达来体现。氨基糖苷类修饰的一个重要机制是通过由氨基糖苷激酶家族催化的ATP依赖性O-磷酸化。这些激酶之一APH(3')-IIIa的结构最近已通过X射线晶体学确定,其总体折叠与真核蛋白激酶惊人地相似(洪,W.C.,麦凯,G.A.,汤普森,P.R.,斯威特,R.M.,杨,D.S.C.,赖特,G.D.,和伯格休斯,A.M.(1997年)《细胞》89卷,887 - 895页)。基于这种相似性,我们研究了已知的真核蛋白激酶抑制剂对两种氨基糖苷激酶APH(3')-IIIa和也表现出乙酰辅酶A依赖性氨基糖苷修饰活性的酶AAC(6')-APH(2")的影响。我们报告说,几种已知的蛋白激酶抑制剂也是氨基糖苷激酶的良好抑制剂。在这方面,属于异喹啉磺酰胺类的化合物特别有效,在微摩尔范围内对ATP产生竞争性抑制,而对氨基糖苷底物产生非竞争性抑制。这项研究为未来氨基糖苷激酶抑制剂的设计以及开发可在临床上逆转抗生素耐药性的化合物提供了基础。